Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jul 1, 2022

Accession no.
0001209191-22-040104
Filed
Jul 1, 2022
Trade date
Jun 1-30, 2022
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.63K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2022Common StockPPurchaseAcquired+38$2.05+$77.921,439Direct
Jun 2, 2022Common StockPPurchaseAcquired+38$2.08+$79.0421,477Direct
Jun 3, 2022Common StockPPurchaseAcquired+38$2.09+$79.4221,515Direct
Jun 6, 2022Common StockPPurchaseAcquired+40$2.07+$82.821,555Direct
Jun 7, 2022Common StockPPurchaseAcquired+30$2.08+$62.421,585Direct
Jun 8, 2022Common StockPPurchaseAcquired+40$2.12+$84.821,625Direct
Jun 9, 2022Common StockPPurchaseAcquired+40$2.09+$83.621,665Direct
Jun 10, 2022Common StockPPurchaseAcquired+40$2.04+$81.621,705Direct
Jun 13, 2022Common StockPPurchaseAcquired+40$2.01+$80.421,745Direct
Jun 14, 2022Common StockPPurchaseAcquired+40$2.02+$80.821,785Direct
Jun 15, 2022Common StockPPurchaseAcquired+40$1.98+$79.221,825Direct
Jun 16, 2022Common StockPPurchaseAcquired+40$1.95+$7821,865Direct
Jun 17, 2022Common StockPPurchaseAcquired+40$1.94+$77.621,905Direct
Jun 21, 2022Common StockPPurchaseAcquired+42$1.97+$82.7421,947Direct
Jun 22, 2022Common StockPPurchaseAcquired+39$1.99+$77.6121,986Direct
Jun 23, 2022Common StockPPurchaseAcquired+42$2.01+$84.4222,028Direct
Jun 24, 2022Common StockPPurchaseAcquired+42$2.11+$88.6222,070Direct
Jun 27, 2022Common StockPPurchaseAcquired+7$2.06+$14.4222,077Direct
Jun 28, 2022Common StockPPurchaseAcquired+37$2.06+$76.2222,114Direct
Jun 29, 2022Common StockPPurchaseAcquired+42$2.11+$88.6222,156Direct
Jun 30, 2022Common StockPPurchaseAcquired+42$2.08+$87.3622,198Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)